Table 9.
Mean gonadotropin doses required to achieve clinical pregnancy/live birth in the 865 ICSI cycles.
| hMG | HP-hMG | r-hFSH | Relative difference, % | ||
| hMG vs r-hFSH | HP-hMG vs r-hFSH | ||||
| Dose per clinical pregnancy, IU* | 7563 | 7258 | 6536 | 15.7 | 11 |
| ≤35 years | 7202 | 6695 | 5942 | 21.2 | 12.7 |
| >35 years | 8456 | 8100 | 8020 | 5.4 | 1 |
| Dose per live birth, IU* | 10,170 | 8390 | 7000 | 45.3 | 19.8 |
| ≤35 years | 9690 | 7739 | 6364 | 52.2 | 21.6 |
| >35 years | 11,371 | 9364 | 8589 | 32.4 | 9 |
Mean gonadotropin doses required to achieve one clinical pregnancy or one live birth are presented, with relative differences for hMG and HP-hMG compared with r-hFSH.
*Calculated as the mean dose per cycle/clinical pregnancy rate or live birth rate.
hMG, human menopausal gonadotropin; HP-hMG, highly purified hMG; ICSI, intracytoplasmic sperm injection; r-hFSH, recombinant human follicle-stimulating hormone.